Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10964792 | Vaccine | 2015 | 5 Pages |
Abstract
In Spain, interim influenza VE estimates over 2010-2014 were a good proxy of the final protection of the vaccine. Interim and final estimates showed greater concordance for all population and if performed subtype-specific.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Silvia Jiménez-Jorge, Francisco Pozo, Amparo Larrauri, The cycEVA Study Team The cycEVA Study Team,